Want to see SE:GENI full AI Analyst Report?
Top Page
Generic Sweden AB
(GENI)
Select Model
Select Model
Rating:79Outperform
Price Target:
kr45.00
▼(-3.12% Downside)
Action:Reiterated
Date:07/09/26
The score is driven primarily by strong financial performance (high profitability, rapid TTM revenue growth, and a zero-debt balance sheet). Valuation is supportive with a moderate P/E and a high dividend yield. Technicals are only moderately positive because the stock is still below the 200-day moving average despite improving shorter-term momentum.
Positive Factors
Balance Sheet Strength
The company carries zero debt across reported periods and has steadily increased equity, materially lowering financial risk and improving capital resilience. A strong, debt-free balance sheet supports durable investment capacity, dividend policy flexibility, and downside protection over months.
Negative Factors
Declining Gross Margin
A multi-year decline in gross margin suggests rising delivery costs, pricing pressure, or adverse mix shifts. If persistent, this trend can compress operating margins and limit the company's ability to sustain current high profitability and reinvestment rates over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
The company carries zero debt across reported periods and has steadily increased equity, materially lowering financial risk and improving capital resilience. A strong, debt-free balance sheet supports durable investment capacity, dividend policy flexibility, and downside protection over months.
Read all positive factors
Generic Sweden AB (GENI) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr468.33M
Dividend Yield3.48%
Average Volume (3M)20.09K
Price to Earnings (P/E)14.8
Beta (1Y)0.47
Revenue Growth4.84%
EPS Growth5.70%
CountrySE
Employees22
SectorGeneral
Sector StrengthN/A
IndustrySoftware - Application
Share Statistics
EPS (TTM)2.52
Shares Outstanding12,292,020
10 Day Avg. Volume18,353
30 Day Avg. Volume20,086
Financial Highlights & Ratios
PEG Ratio1.31
Price to Book (P/B)8.56
Price to Sales (P/S)3.10
P/FCF Ratio14.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.71
Revenue Forecast (FY)kr196.00M
Generic Sweden AB Business Overview & Revenue Model
Company Description
Operating as a technology firm, Generic Sweden AB delivers messaging functionalities compatible with any application. The company additionally furnishes a comprehensive platform dedicated to digital communication services. Established in 1993, its...
Generic Sweden AB Financial Statement Overview
Summary
Income Statement
86
Very Positive
Balance Sheet
92
Very Positive
Cash Flow
78
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 187.78M | 183.71M | 176.45M | 142.59M | 127.73M | 114.23M |
| Gross Profit | 48.13M | 38.81M | 44.72M | 38.27M | 35.54M | 31.93M |
| EBITDA | 39.90M | 39.58M | 35.52M | 30.16M | 26.75M | 24.16M |
| Net Income | 31.07M | 31.04M | 27.25M | 23.31M | 20.45M | 18.13M |
Balance Sheet | ||||||
| Total Assets | 111.30M | 105.14M | 88.97M | 77.42M | 68.04M | 59.42M |
| Cash, Cash Equivalents and Short-Term Investments | 55.76M | 58.24M | 40.62M | 37.20M | 32.60M | 31.07M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 36.94M | 38.55M | 33.75M | 31.01M | 29.57M | 29.11M |
| Stockholders Equity | 74.36M | 66.59M | 55.22M | 46.41M | 38.47M | 30.31M |
Cash Flow | ||||||
| Free Cash Flow | 29.20M | 38.98M | 21.85M | 19.97M | 13.82M | 18.44M |
| Operating Cash Flow | 31.36M | 39.73M | 24.06M | 21.84M | 16.85M | 19.89M |
| Investing Cash Flow | 6.22M | -2.44M | 9.79M | -13.87M | -3.03M | -1.45M |
| Financing Cash Flow | -19.67M | -19.67M | -18.44M | -15.37M | -12.29M | -9.83M |
Generic Sweden AB Peers Comparison
UnderperformOutperform
Sector (55)
SE:GENI
Generic Sweden AB
37.30
-14.80
-28.40%
TFSVF
24SevenOffice
0.99
-0.14
-12.57%
DE:1CW
Sleep Cycle AB
2.11
-0.44
-17.38%
DE:BOJB
BIMobject AB
0.45
-0.09
-16.54%
SE:UPSALE
Upsales Technology AB
27.40
-5.07
-15.62%
SE:CDMIL
Codemill AB
15.05
-2.65
-14.97%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.